Top Markets
Coin of the day
AIxCrypto Holdings, Inc. AIxCrypto Holdings, Inc.

AIxCrypto Holdings, Inc.

AIXC
주식 순위 #27452
AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company... AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing innovative treatments for both adult and pediatric oncology. Its leading investigational therapeutic, QN-302, is a small molecule G-quadruplexes (G4)-selective transcription inhibitor currently progressing through Phase I clinical trials for pancreatic cancer and a range of other solid tumors. The firm is also advancing Pan-RAS, a preclinical-stage program targeting advanced solid tumors. Founded in 1996 and headquartered in Carlsbad, California, the company rebranded from Qualigen Therapeutics, Inc. to AIxCrypto Holdings, Inc. in November 2025.
주가
$1.62
마지막 동기화: 2026-08-19
시가총액
$32.77M
변동 (1일)
22.67%
변동 (1년)
-13.87%
국가
US
거래 AIxCrypto Holdings, Inc. (AIXC)

카테고리

AIxCrypto Holdings, Inc. (AIXC)의 주가 이력
최고 종가: $0.90 (2026-08-01 기준)

최저 종가: $589.38K (2015-06-01 기준)
AIxCrypto Holdings, Inc.의 주가 이력 (2015 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -22.79%
2025 -39.97%
2024 -86.58%
2023 -55.55%
2022 -87.61%
2021 -67.06%
2020 -20.10%
2019 -75.33%
2018 -77.35%
2017 -88.49%
2016 37.25%
2015 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$61.63 67.11%
US
$51.71 74.55%
SE
$196.66 45.99%
FR
$119.62 69.92%
US
$62.87 2.86%
IT